XENETIC BIOSCIENCES, INC. Prepaid Expense and Other Assets, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Prepaid Expense and Other Assets, Current of $182.31 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $182.31K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $247.81K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $166.29K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $946.36K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $182.31K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $247.81K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $166.29K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $946.36K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $573.85K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $313.62K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $421.95K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $188.09K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $716.38K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $552.04K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $603.83K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $1.48M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.32M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $876.54K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $556.09K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $319.10K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $448.73K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $732.37K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $479.40K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $878.24K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $917.83K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.03M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $841.96K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $937.60K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.05M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.31M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $722.08K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $876.82K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.35M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.12M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $555.86K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $610.11K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $675.57K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $343.44K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $285.00K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $1.25M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.43M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.82M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.22M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $930.68K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $171.20K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $236.04K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $247.30K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $195.19K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $129.14K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $87.70K 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $204.01K 10-K · filed 2016-03-30 | $88.24K 10-K · filed 2015-04-15 |
| 2014-09-30 | $239.01K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $423.67K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $329.36K 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $168.31K 10-K · filed 2015-07-20 | |
| 2012-12-31 | $195.91K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |